Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Vitamins and Hormones
|
April 28, 2004
Additive effects of TRAIL and paclitaxel on cancer cells: implications for advances in cancer therapy
Christine Odoux, Andreas Albers
The Pan African Medical Journal
|
November 7, 2019
Rare involvement of paranasal sinuses in sarcoidosis: case report and literature review
Afnan Rajeh, Andreas Albers, Annett Pudszuhn, et al.
Pharmaceutics
|
September 23, 2022
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
Qing Ji, Yuchen Wu, Andreas Albers, et al.
Angewandte Chemie (International Ed. in English)
|
July 11, 2026
T-Shaped Stibenium(III) Cation: Hydrostibination Without Sb─H Bond
Ekta Nag, Lars Ole Busse, Andreas Albers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 25, 2002
Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo
Theresa L Whiteside, Andrea Gambotto, Andreas Albers, et al.
Oncology Reports
|
December 4, 2009
ERCC1 and XPF expression in human testicular germ cell tumors
Beate Köberle, Walburgis Brenner, Andreas Albers, et al.
International Journal of Cancer
|
January 22, 2002
TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer
Christine Odoux, Andreas Albers, Andrew A Amoscato, et al.
Angewandte Chemie (International Ed. in English)
|
March 7, 2024
Predicting Lewis Acidity: Machine Learning the Fluoride Ion Affinity of p-Block-Atom-Based Molecules
Lukas M Sigmund, Shree Sowndarya S, Andreas Albers, et al.
International Journal of Cancer
|
October 30, 2004
Impact of p53-based immunization on primary chemically-induced tumors
Vito R Cicinnati, Grzegorz Dworacki, Andreas Albers, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 4, 2006
The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells
Daisuke Ito, Andreas Albers, Yong Xiang Zhao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Vitamins and Hormones
|
April 28, 2004
Additive effects of TRAIL and paclitaxel on cancer cells: implications for advances in cancer therapy
Christine Odoux, Andreas Albers
The Pan African Medical Journal
|
November 7, 2019
Rare involvement of paranasal sinuses in sarcoidosis: case report and literature review
Afnan Rajeh, Andreas Albers, Annett Pudszuhn, et al.
Pharmaceutics
|
September 23, 2022
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
Qing Ji, Yuchen Wu, Andreas Albers, et al.
Angewandte Chemie (International Ed. in English)
|
July 11, 2026
T-Shaped Stibenium(III) Cation: Hydrostibination Without Sb─H Bond
Ekta Nag, Lars Ole Busse, Andreas Albers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 25, 2002
Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo
Theresa L Whiteside, Andrea Gambotto, Andreas Albers, et al.
Oncology Reports
|
December 4, 2009
ERCC1 and XPF expression in human testicular germ cell tumors
Beate Köberle, Walburgis Brenner, Andreas Albers, et al.
International Journal of Cancer
|
January 22, 2002
TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer
Christine Odoux, Andreas Albers, Andrew A Amoscato, et al.
Angewandte Chemie (International Ed. in English)
|
March 7, 2024
Predicting Lewis Acidity: Machine Learning the Fluoride Ion Affinity of p-Block-Atom-Based Molecules
Lukas M Sigmund, Shree Sowndarya S, Andreas Albers, et al.
International Journal of Cancer
|
October 30, 2004
Impact of p53-based immunization on primary chemically-induced tumors
Vito R Cicinnati, Grzegorz Dworacki, Andreas Albers, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 4, 2006
The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells
Daisuke Ito, Andreas Albers, Yong Xiang Zhao, et al.
Page
of 2